Literature DB >> 1585640

The Helminthosporium victoriae 190S mycovirus has two forms distinguishable by capsid protein composition and phosphorylation state.

S A Ghabrial1, W M Havens.   

Abstract

Purified preparations of the Helminthosporium victoriae 190S (Hv190S) virus contain two sedimenting components that differ in capsid structure. The slower sedimenting component (190S-1) contained p88 and p83 as the major capsid proteins; the faster component (190S-2) contained p88 and p78. Previous peptide-mapping studies have shown the three capsid proteins to be closely related. Analysis by SDS-PAGE of in vivo-radiolabeled Hv190S virions indicated that 32P was predominantly incorporated in p88. Significantly less was detected in p83 and none in p78. Similar results were obtained in in vitro phosphorylation studies using [gamma-32P]ATP and purified 190S-1 and 190S-2. The in vitro results suggest that the Hv190S virions copurify with a protein kinase activity that catalyzes the transfer of gamma-phosphate from ATP to a target protein, presumably p78 in the 190S-2 virions and p83 in the 190S-1 component. Selective chemical cleavage at tryptophan residues of in vitro 32P-labeled capsid proteins revealed four labeled peptides among the cleavage products of both p83 and p88. Radioiodination studies with intact Hv190S virions indicated that p88 and p83, but not the nonphosphorylated p78, were accessible to iodination, suggesting that capsid protein phosphorylation entailed conformational changes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1585640     DOI: 10.1016/0042-6822(92)90520-y

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  9 in total

1.  Organization and expression of the double-stranded RNA genome of Helminthosporium victoriae 190S virus, a totivirus infecting a plant pathogenic filamentous fungus.

Authors:  S Huang; S A Ghabrial
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-29       Impact factor: 11.205

Review 2.  Double-stranded RNA viruses of Saccharomyces cerevisiae.

Authors:  R B Wickner
Journal:  Microbiol Rev       Date:  1996-03

3.  Characterization of Magnaporthe oryzae chrysovirus 1 structural proteins and their expression in Saccharomyces cerevisiae.

Authors:  Syunichi Urayama; Tomoko Ohta; Nobuya Onozuka; Hirofumi Sakoda; Toshiyuki Fukuhara; Tsutomu Arie; Tohru Teraoka; Hiromitsu Moriyama
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

4.  Phosphorylation status of the parvovirus minute virus of mice particle: mapping and biological relevance of the major phosphorylation sites.

Authors:  B Maroto; J C Ramírez; J M Almendral
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

5.  RNA sequence determinants of a coupled termination-reinitiation strategy for downstream open reading frame translation in Helminthosporium victoriae virus 190S and other victoriviruses (Family Totiviridae).

Authors:  Hua Li; Wendy M Havens; Max L Nibert; Said A Ghabrial
Journal:  J Virol       Date:  2011-05-04       Impact factor: 5.103

6.  Protein species of the parvovirus minute virus of mice strain MVMp: involvement of phosphorylated VP-2 subtypes in viral morphogenesis.

Authors:  J F Santarén; J C Ramírez; J M Almendral
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

7.  A novel virus that infecting hypovirulent strain XG36-1 of plant fungal pathogen Sclerotinia sclerotiorum.

Authors:  Liyan Zhang; Yanping Fu; Jiatao Xie; Daohong Jiang; Guoqing Li; Xianhong Yi
Journal:  Virol J       Date:  2009-07-07       Impact factor: 4.099

8.  Three-dimensional structure of victorivirus HvV190S suggests coat proteins in most totiviruses share a conserved core.

Authors:  Sarah E Dunn; Hua Li; Giovanni Cardone; Max L Nibert; Said A Ghabrial; Timothy S Baker
Journal:  PLoS Pathog       Date:  2013-03-14       Impact factor: 6.823

Review 9.  New developments in fungal virology.

Authors:  S A Ghabrial
Journal:  Adv Virus Res       Date:  1994       Impact factor: 9.937

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.